Clinical trial
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
NCT06977074
Study timeline
Study start (actual)2025-05-10Date precision: day
Registry last updated2025-05-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancer (NSCLC)unresolved
Interventions
PD-1 inhibitorDRUG
Platinum DoubletDRUG
Sponsors & collaborators
Sun Yat-sen Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06977074 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.